Literature DB >> 7005035

Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon.

K Breddin, D Loew, K Lechner, K Uberla, E Walter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7005035     DOI： 10.1159/000214375

Source DB:  PubMed          Journal:  Haemostasis        ISSN： 0301-0147


× No keyword cloud information.
  16 in total

Review 1.  Aspirin in patients with coronary artery disease: is it simply irresistible?

Authors:  G V Nair; C J Davis; M E McKenzie; D R Lowry; V L Serebruany
Journal:  J Thromb Thrombolysis       Date:  2001-04       Impact factor: 2.300

2.  Plasma drug and antiplatelet profiles of the original acetylsalicylic acid preparations used in the AMIS, PARIS and German-Austrian trials for secondary prevention of myocardial infarction.

Authors:  R Simrock; K Rehders; H Spahn; E Mutschler; H K Breddin
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 3.  North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group.

Authors:  M Eccles; N Freemantle; J Mason
Journal:  BMJ       Date:  1998-04-25

Review 4.  Platelets, aspirin, and cardiovascular disease.

Authors:  P C Elwood; C Hughes; J R O'Brien
Journal:  Postgrad Med J       Date:  1998-10       Impact factor: 2.401

5.  Oral anticoagulation in patients surviving myocardial infarction. A new approach to old data.

Authors:  E A Loeliger
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

Review 7.  Plasminogen activators and ischemic stroke: conditions for acute delivery.

Authors:  Gregory J del Zoppo
Journal:  Semin Thromb Hemost       Date:  2013-03-28       Impact factor: 4.180

8.  [Effects of acetylsalicylic acid on partial functions of human thrombocytes are not inhibited in vivo by salicylic acid].

Authors:  R Simrock; V Lischke; A Missalla; P Schwidtal; H K Breddin
Journal:  Klin Wochenschr       Date:  1984-03-01

9.  Prophylactic aspirin and risk of peptic ulcer bleeding.

Authors:  J Weil; D Colin-Jones; M Langman; D Lawson; R Logan; M Murphy; M Rawlins; M Vessey; P Wainwright
Journal:  BMJ       Date:  1995-04-01

Review 10.  Risk of haemorrhage associated with long term anticoagulant therapy.

Authors:  M N Levine; G Raskob; J Hirsh
Journal:  Drugs       Date:  1985-11       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.